{"id":"https://openalex.org/W1967462033","doi":"https://doi.org/10.1111/j.1463-1326.2006.00618.x","title":"Topiramate in the treatment of obese subjects with drug\u2010naive type 2 diabetes","display_name":"Topiramate in the treatment of obese subjects with drug\u2010naive type 2 diabetes","alternate_titles":[],"publication_year":2006,"publication_date":"2006-08-04","ids":{"openalex":"https://openalex.org/W1967462033","doi":"https://doi.org/10.1111/j.1463-1326.2006.00618.x","mag":"1967462033","pmid":"https://pubmed.ncbi.nlm.nih.gov/17391164"},"language":"en","primary_location":{"id":"doi:10.1111/j.1463-1326.2006.00618.x","doi":"https://doi.org/10.1111/j.1463-1326.2006.00618.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2006.00618.x","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1967462033"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026334906","display_name":"Kaj Stenl\u00f6f","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801112325","display_name":"Sahlgrenska University Hospital","ror":"https://ror.org/04vgqjj36","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I2801112325"]}],"countries":["SE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"K. Stenl\u00f6f","raw_affiliation_strings":["Sahlgrenska University Hospital, G\u00f6teborg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sahlgrenska University Hospital, G\u00f6teborg, Sweden","institution_ids":["https://openalex.org/I2801112325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089058057","display_name":"Sophia M R\u00f6ssner","orcid":"https://orcid.org/0000-0001-7717-5616","observed_orcids":["https://orcid.org/0000-0001-7717-5616"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. R\u00f6ssner","raw_affiliation_strings":["Huddinge University Hospital, Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huddinge University Hospital, Huddinge, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083959015","display_name":"Frank Vercruysse","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F. Vercruysse","raw_affiliation_strings":["Johnson & Johnson Pharmaceutical Research & Development, LLC, Raritan, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson & Johnson Pharmaceutical Research & Development, LLC, Raritan, NJ, USA","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100613128","display_name":"Amit Kumar","orcid":"https://orcid.org/0000-0002-7326-0036","observed_orcids":["https://orcid.org/0000-0002-7326-0036"]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Kumar","raw_affiliation_strings":["Johnson & Johnson Pharmaceutical Research & Development, LLC, Raritan, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson & Johnson Pharmaceutical Research & Development, LLC, Raritan, NJ, USA","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050887800","display_name":"Martin Fitchet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Fitchet","raw_affiliation_strings":["Johnson & Johnson Pharmaceutical Research & Development, LLC, Raritan, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson & Johnson Pharmaceutical Research & Development, LLC, Raritan, NJ, USA","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109230382","display_name":"Lars Sj\u00f6str\u00f6m","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801112325","display_name":"Sahlgrenska University Hospital","ror":"https://ror.org/04vgqjj36","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I2801112325"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L. Sj\u00f6str\u00f6m","raw_affiliation_strings":["Sahlgrenska University Hospital, Go\u0308teborg, Sweden","Sahlgrenska University Hospital, G\u00f6teborg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sahlgrenska University Hospital, Go\u0308teborg, Sweden","institution_ids":["https://openalex.org/I2801112325"]},{"raw_affiliation_string":"Sahlgrenska University Hospital, G\u00f6teborg, Sweden","institution_ids":["https://openalex.org/I2801112325"]}]},{"author_position":"last","author":{"id":null,"display_name":"Study Group","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801112325","display_name":"Sahlgrenska University Hospital","ror":"https://ror.org/04vgqjj36","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I2801112325"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Study Group","raw_affiliation_strings":["Sahlgrenska University Hospital, Go\u0308teborg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sahlgrenska University Hospital, Go\u0308teborg, Sweden","institution_ids":["https://openalex.org/I2801112325"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5026334906"],"corresponding_institution_ids":["https://openalex.org/I2801112325"],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":null,"fwci":2.9857,"has_fulltext":false,"cited_by_count":78,"citation_normalized_percentile":{"value":0.91216915,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"9","issue":"3","first_page":"360","last_page":"368"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.638700008392334,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.638700008392334,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.34689998626708984,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.003800000064074993,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/topiramate","display_name":"topiramate","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9919999837875366},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.9890000224113464},{"id":"https://openalex.org/keywords/drug-naive-patients","display_name":"drug-naive patients","score":0.9269999861717224},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.7099999785423279},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.8610000014305115},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9070000052452087},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9679999947547913},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.6890000104904175},{"id":"https://openalex.org/keywords/urinary-albumin-excretion","display_name":"urinary albumin excretion","score":0.9610000252723694},{"id":"https://openalex.org/keywords/lifestyle-intervention","display_name":"lifestyle intervention","score":0.5830000042915344},{"id":"https://openalex.org/keywords/central-nervous-system-adverse-events","display_name":"central nervous system adverse events","score":0.8360000252723694}],"concepts":[{"id":"https://openalex.org/C2777683783","wikidata":"https://www.wikidata.org/wiki/Q221174","display_name":"Topiramate","level":3,"score":0.982393741607666},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.8166406750679016},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7812089920043945},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6539157629013062},{"id":"https://openalex.org/C2780221984","wikidata":"https://www.wikidata.org/wiki/Q131191","display_name":"Body mass index","level":2,"score":0.6229069828987122},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5968400835990906},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5457290410995483},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.4786980450153351},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44497740268707275},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.43476125597953796},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.41871386766433716},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.22590702772140503},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.07552757859230042},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0580655038356781},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077236","descriptor_name":"Topiramate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000419","descriptor_name":"Albuminuria","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009422","descriptor_name":"Nervous System Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015431","descriptor_name":"Weight Loss","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019440","descriptor_name":"Anti-Obesity Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019440","descriptor_name":"Anti-Obesity Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D050356","descriptor_name":"Lipid Metabolism","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1463-1326.2006.00618.x","doi":"https://doi.org/10.1111/j.1463-1326.2006.00618.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2006.00618.x","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:17391164","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17391164","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320332194","display_name":"Johnson and Johnson","ror":"https://ror.org/03qd7mz70"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1964227153","https://openalex.org/W1974311184","https://openalex.org/W1980235427","https://openalex.org/W1987334833","https://openalex.org/W1988781925","https://openalex.org/W2021385303","https://openalex.org/W2024754202","https://openalex.org/W2029035160","https://openalex.org/W2029046331","https://openalex.org/W2031386195","https://openalex.org/W2032048326","https://openalex.org/W2049202334","https://openalex.org/W2067753412","https://openalex.org/W2071674869","https://openalex.org/W2089082626","https://openalex.org/W2108740579","https://openalex.org/W2110791445","https://openalex.org/W2113215554","https://openalex.org/W2130908384","https://openalex.org/W2146006491","https://openalex.org/W2151976752","https://openalex.org/W2154068893","https://openalex.org/W2157135485","https://openalex.org/W2166321747","https://openalex.org/W2170034991","https://openalex.org/W2179275138","https://openalex.org/W2400470022"],"related_works":["https://openalex.org/W2017173413","https://openalex.org/W2008985927","https://openalex.org/W2112307228","https://openalex.org/W4242214878","https://openalex.org/W2052347592","https://openalex.org/W2157689819","https://openalex.org/W2285890040","https://openalex.org/W1980235427","https://openalex.org/W4235695208"],"abstract_inverted_index":{"AIM:":[0],"The":[1,111,209],"aim":[2],"of":[3,13,41,52,133,172,191,239,287],"this":[4],"study":[5,112],"was":[6,113,156,213,241],"to":[7,18,70,92,248,259],"examine":[8],"the":[9,57,60,81,88,136,146,170,175,177,285,291],"efficacy":[10,116],"and":[11,20,45,48,107,162,181,189,216,230,266],"safety":[12,141,147],"topiramate":[14,94,98,178,182,240],"as":[15,255],"an":[16,256],"adjunct":[17],"diet":[19],"exercise":[21],"in":[22,63,145,211,270,290],"drug-naive,":[23],"obese":[24],"subjects":[25,89,137,273],"with":[26,33,130,274],"type":[27,34,275],"2":[28,35,276],"diabetes.":[29,277],"METHODS:":[30],"Drug-naive":[31],"individuals":[32,61],"diabetes,":[36],"body":[37,194],"mass":[38],"index":[39],"(BMI)":[40],">":[42],"or":[43,97],"=27":[44],"<50":[46],"kg/m(2)":[47,161],"haemoglobin":[49],"A(1c)":[50],"(HbA(1c))":[51],"<10.5%":[53],"were":[54,90,102,118,143,245],"enrolled":[55],"into":[56],"study.":[58],"All":[59,135],"participated":[62],"a":[64,84,121,234],"non-pharmacologic":[65],"weight":[66,155,195,264],"loss":[67,265],"program":[68],"(Pathways":[69],"Change((R));":[71],"Johnson":[72,74],"&":[73],"Healthcare":[75],"Systems,":[76],"Piscataway,":[77],"NJ,":[78],"USA)":[79],"throughout":[80],"trial.":[82],"After":[83],"6-week":[85],"placebo":[86],"run-in,":[87],"randomized":[91],"placebo,":[93,176,201,223],"96":[95,179],"mg/day":[96,180,184],"192":[99,183],"mg/day.":[100],"Subjects":[101],"scheduled":[103],"for":[104,120],"8-week":[105],"titration":[106],"52-week":[108],"maintenance":[109],"phases.":[110],"ended":[114],"early;":[115],"data":[117,142],"reported":[119],"predefined":[122],"modified":[123],"intent-to-treat":[124],"(MITT)":[125],"population":[126,148,203],"(n":[127,149],"=":[128,150],"229),":[129],"40":[131],"weeks":[132],"treatment.":[134],"who":[138],"provided":[139],"any":[140],"included":[144],"535).":[151],"RESULTS:":[152],"Baseline":[153],"mean":[154],"103.7":[157],"kg,":[158],"BMI":[159],"36":[160],"HbA(1c)":[163,212,236],"6.7%":[164],"across":[165],"all":[166],"treatment":[167,258,279],"groups.":[168],"By":[169],"end":[171],"week":[173],"40,":[174],"groups":[185],"lost":[186],"2.5,":[187],"6.6":[188],"9.1%":[190],"their":[192],"baseline":[193],"respectively":[196,218],"(p":[197,219],"<":[198,220],"0.001":[199,221],"vs.":[200,222],"MITT":[202],"using":[204],"last":[205],"observation":[206],"carried":[207],"forward).":[208],"decrease":[210],"0.2,":[214],"0.6":[215],"0.7%":[217],"MITT).":[224],"Topiramate":[225,254],"significantly":[226],"reduced":[227],"blood":[228],"pressure":[229],"urinary":[231],"albumin":[232],"excretion;":[233],"weight-loss-independent":[235],"improving":[237],"effect":[238],"demonstrated.":[242],"Adverse":[243],"events":[244,289],"predominantly":[246],"related":[247],"central":[249],"nervous":[250],"system":[251],"(CNS).":[252],"CONCLUSIONS:":[253],"add-on":[257],"lifestyle":[260],"improvements":[261],"produced":[262],"significant":[263],"improved":[267],"glucose":[268],"homeostasis":[269],"obese,":[271],"drug-naive":[272],"These":[278],"advantages":[280],"should":[281],"be":[282],"balanced":[283],"against":[284],"occurrence":[286],"adverse":[288],"CNS.":[292]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1967462033","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
